StreetAlpha.app
Home › Stocks › SGP

SpyGlass Pharma, Inc. (SGP)

$30.43
▼ −1.14%
LAST CLOSE · NOV 20

SpyGlass Pharma develops an eye lens with drug pads that releases glaucoma medicine over time, for use during cataract surgery. It last closed at $30.43 on Nov 20, down 1.14% on the day. The next earnings report for SGP is expected around Thu, Mar 25, 2027, after the close. For the quarter ended Sep 2026, SGP reported EPS of -$0.73. Over its last 4 reports the stock moved an average of 5.4% the session after earnings. Over the last 12 months SGP insiders bought $221.5M of stock on the open market and sold $0, according to SEC Form 4 filings.

AI Auto Pilots
Is SGP in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold SGP.

Key Stats

Last 12 months
Results
Net income
−$70.5M
EPS (diluted)
−$7.70
Free cash flow
−$59.2M
Valuation
Market cap
$1.0B
33.5M shares
P/E
–
No P/E while losing money
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$208.7M
At Sep 30
Shareholder equity
$210.4M
Shares outstanding
33.5M
At Nov 2
Fiscal year endsDecember
ExchangeNasdaq
Financials history
FY2024: −$29.2M−$29.2MFY2024FY2025: −$39.9M−$39.9MFY2025

From SGP's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 12). Last 12 months adds up the four latest quarters.

Next report
Mar 25
Estimated date · After the close
Reported EPS
-$0.73
Quarter ended Sep 2026
Year ago EPS
-$4.53
Same quarter last year
Revenue
—
Last reported quarter
Estimates and implied move
Consensus forecasts and the move options price in
EPS by quarter (GAAP)
Mar 2025: -$3.96Mar '25Jun 2025: -$3.81Jun '25Sep 2025: -$4.53Sep '25Dec 2025: -$5.70Dec '25Mar 2026: -$0.69Mar '26Jun 2026: -$0.59Jun '26Sep 2026: -$0.73Sep '26Latest -$0.73
Revenue by quarter
Not enough quarters on file yet.
How SGP moved after its last 4 reports
Average move the session after a report ±5.4%
Nov 12, 2026Time not announced−4.7%
Aug 6, 2026After the close+2.3%
May 14, 2026After the close−4.4%
Mar 26, 2026After the close−10.3%
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha's call on SGPStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in

Analyst Ratings & Price Targets

Analyst Ratings →
AI Starter and AI Pro
Full analyst coverage on SGP
  • Every upgrade, downgrade and initiation as it happens
  • Every price target change, raised or cut
  • Consensus rating with the average, high and low targets
  • Each firm's full rating history on SGP

Technical Analysis

SGP · as of the Nov 20 close · updated each morning
Moving sideways

The stock sits between its 20 and 50 day averages. It is 18% above its 200 day average, so the longer trend is still up. Momentum is fading (RSI 47). The nearest support is the Pivot at $30.41, and the nearest resistance the Pivot R1 at $31.75.

Short trendNeutral
Long trendBullish
MomentumFading
StretchNormal
VolatilityHigh, 8.0%/day
Key levels
$39.9252 week high+31.2%
$39.92Swing high (Nov 9)+31.2%
$33.0120 day average+8.5%
$31.75Pivot R1+4.3%
$30.43Last close
$30.41Pivot−0.1%
$29.09Pivot S1−4.4%
$29.0750 day average−4.5%
$27.00Swing low (Sep 15)−11.3%
$26.49100 day average−12.9%
$25.05200 day average−17.7%
$17.0652 week low−43.9%
Indicators
RSI (14)47.06Middle of its rangeNeutral
MACD0.68Below its signal lineBearish
Stochastic16.6Near the bottom of its rangeOversold
ADX (14)26.5Trending down
Williams %R-79.2Oversold below −80, overbought above −20Neutral
CCI (20)-90.7Oversold below −100, overbought above 100Neutral
Rate of change−17.6%Change over 10 sessionsBearish
ATR (14)$2.43Typical daily range, 8.0% of price
MA 10Below
MA 20Below
MA 50Above
MA 100Above
MA 200Above
What happened before, for SGP

What happened before

See how SGP did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.

Whale Options Flow

90D
Whale options flow for SGPHow many large options trades hit SGP, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in

See today’s whale options flow across the market →

SGP Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Bullish
Strongly bearishNeutralStrongly bullish
  • ▲38 buying vs 24 selling
  • ▲Held by funds +0.8 pts
  • ▲Funds holding +18
  • ▼Superinvestors: 0 added, 1 cut
  • ●Put/call not meaningful
Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding7052+34.6%
In funds' top 1043+33.3%
Held by funds78.9%78.1%+0.8 pts
New / increased21 / 1722 / 17−2.6%
Reduced / sold out21 / 35 / 5+140.0%
Put/call ratio–––
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See SGP institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

SGP Insider Trading

All filings →
Insider trading · 12 months
Insiders are net buyers
Bought$221.5M16 buys · 16 insiders
Sold$00 sales · 0 insiders
Cluster buy: 15 insiders bought $221.5M between Feb 9 and Feb 9.
2026-02 bought $221.5M2026-11 bought $32KDecMarJunSep
BoughtSoldlast 12 months
Trade dateInsiderTypeSharesPriceValue
Nov 16Ra Capital Management, L.P.DirectorBuy1,000$32.43$32K
Feb 9Paul Edward Walker10% ownerBuy937,500$16.00$15.0M
Feb 9Carmen Chang10% ownerBuy937,500$16.00$15.0M
Feb 9Edward T Mathers10% ownerBuy937,500$16.00$15.0M
Feb 9Scott D Sandell10% ownerBuy937,500$16.00$15.0M
Feb 9Mohamad Makhzoumi10% ownerBuy937,500$16.00$15.0M
Every insider buy and sale for SGP over 2 years, with a link to each SEC filing. AI Pro members can get an alert the moment an insider trades.See SGP insider trades →

From SEC Form 4 filings by SGP's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.

AI Auto Pilots

Paper trading

StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether SGP is in one of them and how their past SGP trades turned out.

SGP in the AI portfolios
Loading…

SGP News Tone and Price

Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered SGP in an article yet. Here's the latest on the wider market.

SGP in the news

About SpyGlass Pharma

SpyGlass Pharma is a biopharmaceutical company based in Irvine, California, that develops long lasting drug delivery products for people with chronic eye conditions. Its lead product candidate is an intraocular lens fitted with drug pads that releases bimatoprost, a medicine already approved for topical use, to lower eye pressure in patients with glaucoma or ocular hypertension. The lens is designed to be implanted during routine cataract surgery, so its main customers are cataract surgeons and the patients they treat. The product is still in clinical trials and is not yet approved for sale.

Headquarters
Irvine, CA